Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
about
Lipoprotein genotype and conserved pathway for exceptional longevity in humansEffects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceRegulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acidDietary approach in the treatment of nonalcoholic fatty liver diseaseRedox regulation of FoxO transcription factorsNew Era of Lipid-Lowering DrugsForkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathyFoxO1 mediates insulin-dependent regulation of hepatic VLDL production in miceApolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee.Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).Leptin and insulin signaling in dopaminergic neurons: relationship between energy balance and reward system.FoxO1 links hepatic insulin action to endoplasmic reticulum stress.Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1.The expression of type III hyperlipoproteinemia: involvement of lipolysis genesPlasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.A role of apolipoprotein D in triglyceride metabolismRacial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins.Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene.Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.Role of PPARα and HNF4α in stress-mediated alterations in lipid homeostasisInsulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c.Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosisEarly-life physical activity reverses metabolic and Foxo1 epigenetic misregulation induced by gestational sleep disturbance.Pathophysiology of diabetic dyslipidaemia: where are we?FoxO6 integrates insulin signaling with gluconeogenesis in the liver.Isotretinoin and FoxO1: A scientific hypothesis.Updating experimental models of diabetic cardiomyopathyDissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in miceFoxO1, the transcriptional chief of staff of energy metabolism.Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.Hepatic ABCA1 and VLDL triglyceride production.Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1.FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxisFOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival.NOX4 pathway as a source of selective insulin resistance and responsivenessThe ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fatFOXO1 Up-Regulates Human L-selectin Expression Through Binding to a Consensus FOXO1 Motif.
P2860
Q21146060-2FFAE025-D68C-4E28-BBC6-16823911C989Q24302828-64B496DF-1554-4BC5-94E7-8139FEFCF676Q24594113-14696954-2ECC-4912-B7F0-58228FB1AC33Q26777508-482A862C-345D-49E7-9CE1-D0775A204709Q26799843-3E73B4F0-3533-489A-A392-2FEE358623EBQ28072298-C5320A0C-B4DE-49E9-91D1-AD79D3D98625Q28080067-361F83C4-5AA3-4026-9EA5-1425CCC8CC13Q28507512-E68E0658-5FE5-412E-BD1A-5F723B0E0D4FQ33572201-15BEF191-1300-49E9-BD8B-5E6E918A5425Q33727061-C11AAEE3-609B-41E6-A92A-7B74008BF3DAQ33740554-724A50D1-FF39-4336-AF1B-2DE55FA0F11EQ33864337-84964C8F-4403-40B8-BE50-6E16EF4B9CBDQ34014371-B49DB601-4B8B-47BB-9D8A-722DF132374AQ34132566-BD5063E5-6A96-483B-8278-63B8B47B6C30Q34163992-02DA2D3C-117E-423D-A18C-7A8BF20A7F02Q34188064-4D752B5D-A938-40C0-AFA0-E43ABF4B34E1Q34326186-92C8D39A-AC79-4527-A6BF-519B91E8EE6FQ34480492-9BB92808-7328-46CB-A2BD-DDDA7B74D052Q34559829-88AFAFF6-C470-4F1E-95C5-0C65429BFFE7Q34793857-3F3E6B9A-8723-4E17-B7BF-443A4E6B6D5FQ34800558-04C2245A-1159-4A0C-8A8A-AA15D0430762Q34945194-D1DF1C5A-C026-484B-9F89-3FB29BC28C1DQ34962631-5FEB964D-89FF-41A6-AC64-85981D1D1472Q35049218-8F1D0670-FBD5-47CE-A9BF-E7156CA45492Q35086814-CBF505B5-47D1-4B7C-A9C3-C4E0E41FC0D3Q35138553-73A3955C-4DB6-4F10-9B55-303DF548F803Q35350326-76313D1C-AE62-446D-88A3-945613301B76Q35405206-3146E615-A755-47D7-85D6-34AD6064C339Q35558873-93F1C3AE-0345-4AB2-B959-94C3FB16CC0CQ35564129-4040FC92-8911-43D6-BC70-75FB0BB09A09Q35565619-C880C44C-A59F-41B1-8A50-F2385CF138C1Q35587183-D1B066F3-78BE-4EAD-89D7-246EF0775D16Q35644730-0CAE5614-C4D2-489F-9868-46BFAEAE4F39Q35737630-02C057E5-3CA7-413E-9F8C-67F14B846E22Q35743984-85D216AC-90D1-4ECD-B5D5-98D5F0CCAD25Q35776345-E016B159-3B78-49B6-A60F-53CD25501B1DQ36065490-2EEB8A60-26D2-4D12-A7D1-847846E92DF3Q36099612-ACCF264D-9615-453D-966F-4CDA816D1BD5Q36213841-3E14CF3F-B222-41B3-B8FA-A2B87EE4B141Q36364938-FFB05144-98A6-44A4-81BE-BD92D04222FB
P2860
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
@en
type
label
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
@en
prefLabel
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
@en
P2093
P2860
P356
P1476
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
@en
P2093
Anja Richter
Marcia Meseck
Sonal Harbaran
P2860
P304
P356
10.1172/JCI200419992
P407
P577
2004-11-01T00:00:00Z